Creating a risk score for blood clot recurrence and bleeding in cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active cancer (any type).
- You've had a blood clot in a deep vein of an arm or leg (DVT), in your lungs (PE), in your belly (splanchnic vein), or in your brain sinuses (cerebral sinus vein).
- You plan to take blood thinners for at least 6 months.
- You are 18 or older.
- Doctors expect you to live more than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
This study tests how well a scoring system (CLOVER) can detect undiagnosed cancer in people who have had a blood clot (deep vein thrombosis or pulmonary embolism). Researchers want to see if the score can predict hidden cancer, which may lead to earlier treatment.
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Hear when a new Cancer-associated Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.